Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Armata Pharmaceuticals, Inc. (ARMP) had Operating Cash Flow per Share of $-1.31 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$4.53M |
|
$-69.05M |
|
-- |
|
$4.53M |
|
$45.42M |
|
$-40.89M |
|
$-28.16M |
|
$-69.05M |
|
$-69.05M |
|
$-69.05M |
|
$-69.05M |
|
$-69.05M |
|
$-69.05M |
|
$-40.89M |
|
$-39.92M |
|
36.08M |
|
36.08M |
|
$-1.91 |
|
$-1.91 |
|
| Balance Sheet Financials | |
$19.15M |
|
$12.56M |
|
$79.21M |
|
$98.36M |
|
$16.46M |
|
$82.31M |
|
$113.97M |
|
$130.43M |
|
$-32.06M |
|
$-35.55M |
|
$-32.06M |
|
36.12M |
|
| Cash Flow Statement Financials | |
$-47.42M |
|
$-8.13M |
|
$53.99M |
|
$20.81M |
|
$19.24M |
|
$-1.57M |
|
$0.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.16 |
|
-- |
|
-- |
|
1.64 |
|
-2.57 |
|
100.00% |
|
-902.85% |
|
-902.85% |
|
-881.39% |
|
-1524.51% |
|
-1524.51% |
|
$-55.56M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
1.35 |
|
271.03 |
|
215.33% |
|
194.19% |
|
-70.19% |
|
-137.42% |
|
$-0.89 |
|
$-1.54 |
|
|
Operating Cash Flow per Share |
$-1.31 |